How cells respond to interferons revisited: from early history to current complexity.
about
Bivariate genetic association of KIAA1797 with heart rate in American Indians: the Strong Heart Family StudyHepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphismsMKP-1: a critical phosphatase in the biology of macrophages controlling the switch between proliferation and activationSelf-termination of the terminatorSTAT6 expression in glioblastoma promotes invasive growthEnhanced interferon signaling pathway in oral cancer revealed by quantitative proteome analysis of microdissected specimens using 16O/18O labeling and integrated two-dimensional LC-ESI-MALDI tandem MSDisruption of type I interferon signaling by the nonstructural protein of severe fever with thrombocytopenia syndrome virus via the hijacking of STAT2 and STAT1 into inclusion bodiesInterferon-inducible IFI16, a negative regulator of cell growth, down-regulates expression of human telomerase reverse transcriptase (hTERT) gene.TLR7 stimulation in human plasmacytoid dendritic cells leads to the induction of early IFN-inducible genes in the absence of type I IFNPathogen recognition receptor signaling accelerates phosphorylation-dependent degradation of IFNAR1STAT1 signaling is essential for protection against Cryptococcus neoformans infection in mice.Toxoplasma gondii triggers phosphorylation and nuclear translocation of dendritic cell STAT1 while simultaneously blocking IFNγ-induced STAT1 transcriptional activityDifferential roles for the interferon-inducible IFI16 and AIM2 innate immune sensors for cytosolic DNA in cellular senescence of human fibroblasts.Protein kinase R as mediator of the effects of interferon (IFN) gamma and tumor necrosis factor (TNF) alpha on normal and dysplastic hematopoiesisTyrosine phosphorylation of protein kinase D2 mediates ligand-inducible elimination of the Type 1 interferon receptor.Free ISG15 triggers an antitumor immune response against breast cancer: a new perspective.Production and characterization of thirteen human type-I interferon-α subtypes.The influence of treatment with pegylated interferon-alfa and ribavirin on neutrophil function and death in patients with HIV/HCV coinfection.IFN-γ synergistically enhances LPS signalling in alveolar macrophages from COPD patients and controls by corticosteroid-resistant STAT1 activation.IFNγ Regulates Activated Vδ2+ T Cells through a Feedback Mechanism Mediated by Mesenchymal Stem CellsG-CSF-activated STAT3 enhances production of the chemokine MIP-2 in bone marrow neutrophils.Sprouty proteins are negative regulators of interferon (IFN) signaling and IFN-inducible biological responsesBRD4 coordinates recruitment of pause release factor P-TEFb and the pausing complex NELF/DSIF to regulate transcription elongation of interferon-stimulated genesOrganization of the mouse RNA-specific adenosine deaminase Adar1 gene 5'-region and demonstration of STAT1-independent, STAT2-dependent transcriptional activation by interferon.Glycogen synthase kinase-3 promotes the synergistic action of interferon-gamma on lipopolysaccharide-induced IL-6 production in RAW264.7 cellsUnphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes.Induction of TRIM22 by IFN-γ Involves JAK and PC-PLC/PKC, but Not MAPKs and pI3K/Akt/mTOR Pathways.Type I interferon (IFN)-dependent activation of Mnk1 and its role in the generation of growth inhibitory responses.Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases.The P Protein of Spring Viremia of Carp Virus Negatively Regulates the Fish Interferon Response by Inhibiting the Kinase Activity of TANK-Binding Kinase 1.Critical roles for Rictor/Sin1 complexes in interferon-dependent gene transcription and generation of antiproliferative responses.Correlation between the suppressor of cytokine signaling-1 and 3 and hepatitis B virus: possible roles in the resistance to interferon treatment.IFN-beta pharmacogenomics in multiple sclerosis.Chronic myeloid leukemia stem cells and developing therapies.The executioners sing a new song: killer caspases activate microglia.Interferons as biomarkers and effectors: lessons learned from animal models.Signal, transduction, and the hematopoietic stem cell.Role of Viral Hemorrhagic Septicemia Virus Matrix (M) Protein in Suppressing Host Transcription.Microglial Interferon Signaling and White Matter.Organ system view of the hepatic innate immunity in HCV infection.
P2860
Q24626784-00DD92CD-33D4-4C04-9728-AB4310988150Q26738545-58E1631A-B282-4D45-8CCB-898D31ECA116Q27005974-7516B36C-FBB4-4DF8-9204-AB08F07D9893Q28118772-78D2F072-D55C-426C-9BFF-A78B906E76D2Q30431789-A34E84D6-0046-4E1F-92EF-17C9FEEC8182Q33419602-0F7690A4-6D4E-4330-8F26-042FA0EDDE1CQ33420049-0B114BEB-C5D6-48E4-A19B-93F0A53C5AF4Q33522211-EC290EE0-EAAE-44CB-AC3B-713704131F2FQ33763210-D8E376B7-B8AF-483B-AECC-D56642B4EE5FQ33939691-79725376-320F-400E-B300-0AB9512C88C2Q34289451-359DA963-E94B-4CC9-BCAD-02C771BC94CDQ34635676-CA2FB597-1A25-4F1E-9AB5-0E5F5BE658BBQ34987881-9F09AF4B-9AAF-4702-B339-76AF62A7A884Q35144933-AA541764-D296-4548-B6D1-5AA6E24B1987Q35372365-219D3775-EED1-4D59-9E72-695E7B7B14BCQ35740189-23155622-8646-442B-A028-151908D7F750Q35740830-FA23C032-CBD7-472F-A91C-D200C3C851D2Q35866167-8734DA52-7257-483A-B42B-6B4600AB0AE0Q36110505-87713220-1B26-4181-B2C1-C6B7688A9E5CQ36246214-725F5E0A-ED6B-43FA-BB08-A8EAF34FE053Q36410811-6ED7D31E-DB6C-42BD-97EB-21507D7411B5Q36452049-20F29AE0-AB21-432A-8548-A3796BA6EF98Q36978246-63F7A5A0-7995-4C2F-A2BD-2CD59081A6F2Q37066513-32C49586-41FC-44A3-91F5-1DA4778C93C9Q37148227-F5161664-FFB4-4CB5-B4D3-80E9B0181653Q37206449-844F4CFF-CEF3-45E4-9708-C78FB5875D21Q37222827-ED37478D-FCB2-4CBD-847B-B5C25B86069EQ37274424-140C8BE8-101B-4DE5-A320-8AE5DAC9BA61Q37414046-D77BC927-EC0D-49A6-A1C2-6BE4DBAEE25CQ37415470-8C44EBE2-9F9C-4290-A5CD-D4C16D2E4B86Q37622557-550F9F51-AB36-4006-9FCA-B02BA4AA98C1Q37716483-0392C926-4879-4C01-BCFE-5298B977DEDFQ37780222-19B035ED-BC4B-4A51-B85E-7C3F6A19B848Q37836936-26CFEF4E-2532-45E6-9A99-8F41C11BE158Q37916221-09764B78-C050-4F3C-9F17-54A4E5EF47FCQ37997045-7C1E645A-22F2-4DC7-90BD-DB466A625E60Q38266904-667806DA-A8CB-47FB-AD08-3EA191681341Q38659332-61E75716-E23A-4B4A-B529-8B8B004D5BB0Q38765964-42C8D5A0-7234-40BE-A39A-78A703ED1633Q38827613-EC49E134-DD9F-4E0A-A5A8-AE07B0DA0E3E
P2860
How cells respond to interferons revisited: from early history to current complexity.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
How cells respond to interferons revisited: from early history to current complexity.
@ast
How cells respond to interferons revisited: from early history to current complexity.
@en
type
label
How cells respond to interferons revisited: from early history to current complexity.
@ast
How cells respond to interferons revisited: from early history to current complexity.
@en
prefLabel
How cells respond to interferons revisited: from early history to current complexity.
@ast
How cells respond to interferons revisited: from early history to current complexity.
@en
P2860
P1476
How cells respond to interferons revisited: from early history to current complexity.
@en
P2093
George R Stark
P2860
P304
P356
10.1016/J.CYTOGFR.2007.06.013
P577
2007-08-01T00:00:00Z